|
US4962115A
(en)
*
|
1981-10-01 |
1990-10-09 |
Janssen Pharmaceutica N.V. |
Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
|
|
US5137896A
(en)
*
|
1981-10-01 |
1992-08-11 |
Janssen Pharmaceutica N.V. |
N-(3-hydroxy-4-piperidinyl)benzamide derivatives
|
|
US5057525A
(en)
*
|
1981-10-01 |
1991-10-15 |
Janssen Pharmaceutica N.V. |
Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
|
|
FR2534255B1
(fr)
*
|
1982-10-11 |
1985-07-12 |
Delalande Sa |
Nouveaux derives de la 4-aroylamino piperidine, leur procede de preparation et leur application en therapeutique
|
|
FR2546169B1
(fr)
*
|
1983-05-20 |
1986-03-21 |
Delalande Sa |
N-oxydes de derives aminocycliques, leur procede de preparation et leur application en therapeutique
|
|
GB8527052D0
(en)
*
|
1985-11-02 |
1985-12-04 |
Beecham Group Plc |
Compounds
|
|
FI95572C
(fi)
*
|
1987-06-22 |
1996-02-26 |
Eisai Co Ltd |
Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
|
|
GB9016581D0
(en)
*
|
1990-07-27 |
1990-09-12 |
Ici Plc |
Fungicides
|
|
GB9016580D0
(en)
*
|
1990-07-27 |
1990-09-12 |
Ici Plc |
Fungicides
|
|
TR27569A
(tr)
*
|
1992-01-24 |
1995-06-13 |
Ici Plc |
Yeni fungisidal asilaminobenzamidler, bunlarin hazirlanis islemleri ve bitkilerdeki mantar enfeksiyonlariyla mücadelede kullanimlari.
|
|
US5739135A
(en)
*
|
1993-09-03 |
1998-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5827875A
(en)
*
|
1996-05-10 |
1998-10-27 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5885983A
(en)
*
|
1996-05-10 |
1999-03-23 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5883109A
(en)
*
|
1996-07-24 |
1999-03-16 |
Bristol-Myers Squibb Company |
Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
|
|
SE9902987D0
(sv)
*
|
1999-08-24 |
1999-08-24 |
Astra Pharma Prod |
Novel compounds
|
|
IL151164A0
(en)
*
|
2000-03-06 |
2003-04-10 |
Acadia Pharm Inc |
Azacyclic compounds for use in the treatment of serotonin related diseases
|
|
CA2406652A1
(en)
*
|
2000-04-20 |
2001-11-01 |
Nps Allelix Corp. |
Aminopiperidines for use as glyt-1 inhibitors
|
|
GB0011838D0
(en)
*
|
2000-05-17 |
2000-07-05 |
Astrazeneca Ab |
Chemical compounds
|
|
RU2286801C2
(ru)
*
|
2001-05-01 |
2006-11-10 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Двухфазные биоадгезионные композиции, абсорбирующие воду
|
|
KR20100008799A
(ko)
*
|
2001-12-28 |
2010-01-26 |
아카디아 파마슈티칼스 인코포레이티드 |
모노아민 수용체 조정자로서의 스피로아자사이클릭 화합물
|
|
US7538222B2
(en)
*
|
2002-06-24 |
2009-05-26 |
Acadia Pharmaceuticals, Inc. |
N-substituted piperidine derivatives as serotonin receptor agents
|
|
US7253186B2
(en)
*
|
2002-06-24 |
2007-08-07 |
Carl-Magnus Andersson |
N-substituted piperidine derivatives as serotonin receptor agents
|
|
BR0312217A
(pt)
*
|
2002-06-24 |
2005-05-10 |
Acadia Pharm Inc |
Compostos, métodos de inibição da atividade/ativação de um receptor monoaminérgico e método de tratamento de condição doentia associada a um receptor de monoaminergético
|
|
MY139563A
(en)
*
|
2002-09-04 |
2009-10-30 |
Bristol Myers Squibb Co |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
|
CN101780080B
(zh)
|
2003-01-16 |
2014-06-04 |
阿卡蒂亚药品公司 |
用于神经退行性疾病的治疗的选择性五羟色胺2a/2c受体反向激动剂
|
|
KR100697944B1
(ko)
*
|
2003-02-10 |
2007-03-20 |
니폰 쇼쿠바이 컴파니 리미티드 |
수분-흡수제
|
|
SE0301369D0
(sv)
*
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
|
US7820695B2
(en)
*
|
2004-05-21 |
2010-10-26 |
Acadia Pharmaceuticals, Inc. |
Selective serotonin receptor inverse agonists as therapeutics for disease
|
|
US20050261278A1
(en)
*
|
2004-05-21 |
2005-11-24 |
Weiner David M |
Selective serotonin receptor inverse agonists as therapeutics for disease
|
|
US7790899B2
(en)
*
|
2004-09-27 |
2010-09-07 |
Acadia Pharmaceuticals, Inc. |
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
|
|
ES2530258T3
(es)
*
|
2004-09-27 |
2015-02-27 |
Acadia Pharmaceuticals Inc. |
Síntesis de una forma cristalina de sal tartrato de N-(4-fluorobencil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metilpropiloxi)fenilmetil)carbamida
|
|
JP2008524276A
(ja)
*
|
2004-12-20 |
2008-07-10 |
エフ.ホフマン−ラ ロシュ アーゲー |
4−アミノピペリジン誘導体
|
|
WO2008116024A2
(en)
|
2007-03-19 |
2008-09-25 |
Acadia Pharmaceuticals Inc. |
Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
|
|
CA2700331A1
(en)
*
|
2007-09-21 |
2009-03-26 |
Acadia Pharmaceuticals, Inc. |
Co-administration of pimavanserin with other agents
|
|
DK3325444T3
(da)
|
2015-07-20 |
2021-10-04 |
Acadia Pharm Inc |
Fremgangsmåder til fremstilling af n-(4-fluorbenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamid og dets tartratsalt og polymorf form c
|
|
US10953000B2
(en)
|
2016-03-25 |
2021-03-23 |
Acadia Pharmaceuticals Inc. |
Combination of pimavanserin and cytochrome P450 modulators
|
|
WO2017165635A1
(en)
|
2016-03-25 |
2017-09-28 |
Acadia Pharmaceuticals Inc. |
Combination of pimavanserin and cytochrome p450 modulators
|
|
EP3558311A1
(en)
|
2016-12-20 |
2019-10-30 |
Acadia Pharmaceuticals Inc. |
Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis
|
|
EP3615028A1
(en)
|
2017-04-28 |
2020-03-04 |
Acadia Pharmaceuticals Inc. |
Pimavanserin for treating impulse control disorder
|
|
EP3675827A1
(en)
|
2017-08-30 |
2020-07-08 |
Acadia Pharmaceuticals Inc. |
Formulations of pimavanserin
|